TherapeuticsMD, Inc. — Director's Dealing 2012

Dec 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2012-11-30

Reporting Person: Milligan John C.K. IV (Director, President/Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-16	Non-qualified Stock Option	$2.55	A	75000	Acquired	2022-04-16	Common Stock (75000)	Direct
2012-11-30	Non-qualified Stock Option	$3.00	A	800000	Acquired	2022-11-30	Common Stock (800000)	Direct

Footnotes

F1: The shares under the 11/30/12 stock option for the purchase of 800,000 shares vest at the rate of 266,666 on 11/8/13, 266,667 on 11/8/14 and 266,667 on 11/8/15.